The 2910 nm fiber laser system for skin resurfacing and rejuvenation will be introduced to clinics nationwide by a Canadian distributor.
US-based Acclaro Medical, specializing in energy-based technologies for aesthetic, ophthalmic, and surgical markets, announced the approval of its flagship UltraClear 2910 nm cold ablative fiber laser by Health Canada.
This clearance brings the skin rejuvenation platforms to Canadian providers and patients. Acclaro Medical has also partnered with Xcite Technology, an energy-based device distributor, to spearhead commercialization efforts across Canada.
Engineered with proprietary MID IR Fiber Laser and 3DIntelliPulse technology, UltraClear is a 2910 nm cold ablative fiber offering customizable treatments designed to address superficial to deep skin concerns with minimal downtime and patient comfort. Its treatment modes, including 3DMIRACL for gentle resurfacing and Laser Coring, aim to help reverse telltale signs associated with aging and gravity.
“The approval of our UltraClear in Canada as the first and only 2910 nm fiber laser marks a significant milestone in our steadfast commitment to bringing breakthrough innovation to Canadian aesthetic providers and their patients,” says Helen Fang, CEO of Acclaro Medical, in a release. “Across Acclaro Medical, we are proud of our shared vision to deliver category-defining solutions for a full range of patient-friendly treatment options tailored to their needs, lifestyles, and skin types.”
As the exclusive Canadian distributor, Xcite Technologies will bring UltraClear to aesthetic clinics nationwide.
“UltraClear is unlike anything currently available,” said Bill Roberts, CEO of Xcite Technologies, in a release. “The 2910 nm cold ablative fiber laser combined with proprietary Laser Coring technology delivers a level of precision, depth, and patient comfort that truly redefines what’s possible in skin rejuvenation. This is a major step forward for Canadian providers looking to offer high-efficacy treatments with minimal downtime and broad patient appeal.”
Photo caption: UltraClear 2910 nm fiber laser
Photo credit: PRNewsfoto/Acclaro Medical Corp
